Highly efficient elimination of Philadelphia leukemic cells by exposure to bcr/abl antisense oligodeoxynucleotides combined with mafosfamide.
Synthetic oligodeoxynucleotides complementary to the break-point junction of bcr-abl transcripts selectively inhibit the proliferation of Philadelphia-positive leukemic cells, but residual leukemic cells persist in antisense oligodeoxynucleotides-treated cultures. Cyclophosphamide derivatives such a...
Sparad:
| I publikationen: | J Clin Invest |
|---|---|
| Huvudupphov: | , , , , , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Utgiven: |
American Society for Clinical Investigation
1993
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC293565/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8325984/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI116549 |
| Taggar: |
Inga taggar, Lägg till första taggen!
|
